Document is current
Any future updates will be listed below
-
Authors
Bellon, Marcia
Bialuk, Izabela
Galli, Veronica
Bai, Xue-Tao
Farre, Lourdes
Bittencourt, Achilea
Marçais, Ambroise
Petrus, Michael N.
Ratner, Lee
Waldmann, Thomas A.
Asnafi, Vahid
Gessain, Antoine
Matsuoka, Masao
Franchini, Genoveffa
Hermine, Olivier
Watanabe, Toshiki
Nicot, Christophe https://orcid.org/0000-0001-5927-2869
-
Funding
Funding for this research was provided by:
Division of Cancer Epidemiology and Genetics, National Cancer Institute (R01CA201309)
- License Information
-
More Information
Article History
Received: 16 March 2021
Accepted: 12 May 2021
First Online: 6 June 2021
Declarations
:
: This retrospective cross-sectional study was carried out using collected and frozen PBMCs. All samples used here are part of previous studies, for which these samples were collected after informed consent and approved by appropriate institutional review boards. A portion of the TSP/HAM samples were donated following written informed consent, by patients attending the National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, to the Communicable Disease Research Tissue Bank of Imperial College London. The use of the samples was approved by the steering committee of the Tissue Bank under the authority delegated by the National Research Ethics Service (NRES reference 15/SC/0089; 20/SC 0226. A portion of HTLV carriers was kindly donated from the nationwide cohort study for asymptomatic HTLV-1 carriers in Japan (Joint Study on Predisposing Factors of ATL Development (JSPFAD)).
: Not Applicable.
: The authors declare no competing financial interests.
